RT-PCR Database Analysis for COVID-19 Infections and Re-infection

SARS-Cov2 (COVID-19) Infection and Reinfection Through the Analysis of a RT-PCR Results Database

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04653844

Acronym

ReCOV

Enrollment

7000000

Registered

2020-12-04

Start date

2020-02-01

Completion date

2023-01-30

Last updated

2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19, SARS-CoV Infection

Keywords

SARS-Cov2 infection, Positive SARS-Cov2 RT-PCR, SARS-Cov2 immune status, reinfection, kinetics, Rt-PCR, immunity

Brief summary

The SARS-Cov2 pandemic remains associated with many concerns. One of the them is the real frequency of likely re-infection and subsequently the level of protection conferred by the acquired immunity following primary-infection. We propose to analyze a large set of laboratory data produced since the early beginning of the SARS-Cov2 spread in the French population to identify recurrent infection events and, more generally, gain insight about infection kinetics.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

\- People with at least one positive SARS-Cov2 RT-PCR result with a known sampling date

Exclusion criteria

\- Patient refusing to participate in research

Design outcomes

Primary

Measure	Time frame	Description
SARS-CoV-2 reinfection rate	1 day	SARS-CoV-2 reinfection rate

Countries

France

Contacts

Primary ContactSamuel Alizon, PhD

samuel.alizon@cnrs.fr610654902

Backup ContactVincent Foulongne, PhD

v-foulongne@chu-montpellier.fr467 330 254

Outcome results